The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
 
Vivianne C. Tjan-Heijnen
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Irene Van Hellemond
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Roche
 
Ingeborg Vriens
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Roche
 
Petronella Peer
Research Funding - AstraZeneca (Inst)
 
Astrid Swinkels
Research Funding - AstraZeneca (Inst)
 
Carolien H. Smorenburg
No Relationships to Disclose
 
Maurice Van Der Sangen
No Relationships to Disclose
 
Judith R. Kroep
Research Funding - Amgen (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis
 
Hiltje de Graaf
No Relationships to Disclose
 
Aafke H. Honkoop
No Relationships to Disclose
 
Frans Erdkamp
No Relationships to Disclose
 
Franchette van den Berkmortel
No Relationships to Disclose
 
Maaike De Boer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche
 
Wilfred de Roos
Research Funding - AstraZeneca (Inst)
 
Sabine C. Linn
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche/Genentech
 
Alexander Imholz
Research Funding - AstraZeneca (Inst)
 
Caroline Seynaeve
No Relationships to Disclose